These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19669848)

  • 1. High incidence of complications from enoxaparin treatment after arthroplasty.
    Neviaser AS; Chang C; Lyman S; Della Valle AG; Haas SB
    Clin Orthop Relat Res; 2010 Jan; 468(1):115-9. PubMed ID: 19669848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group.
    Leclerc JR; Gent M; Hirsh J; Geerts WH; Ginsberg JS
    Arch Intern Med; 1998 Apr; 158(8):873-8. PubMed ID: 9570173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant treatment of thromboembolism with intravenous heparin therapy in the early postoperative period following total joint arthroplasty.
    Della Valle CJ; Jazrawi LM; Idjadi J; Hiebert RN; Stuchin SA; Steiger DJ; Di Cesare PE
    J Bone Joint Surg Am; 2000 Feb; 82(2):207-12. PubMed ID: 10682729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin.
    Ricket AL; Stewart DW; Wood RC; Cornett L; Odle B; Cluck D; Freshour J; El-Bazouni H
    Ann Pharmacother; 2016 Apr; 50(4):270-5. PubMed ID: 26783354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine monitoring for heparin-induced thrombocytopenia following lower limb arthroplasty: Is it necessary? A prospective study in a UK district general hospital.
    Haughton B; Haughton J; George Norman J; Navid A; Allport K; Andrews M; Mannan K; Livesey J
    Orthop Traumatol Surg Res; 2019 May; 105(3):497-501. PubMed ID: 30878232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.
    Squizzato A; Lussana F; Cattaneo M
    Thromb Haemost; 2015 Aug; 114(2):237-44. PubMed ID: 25946985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
    Fuji T; Ochi T; Niwa S; Fujita S
    J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thromboprophylaxis with enoxaparin for total knee replacement: an observational, retrospective and multicentre study comparing starting the treatment before and after the operation].
    Llau JV; Gil-Garay E; Castellet E;
    Rev Esp Anestesiol Reanim; 2012; 59(6):306-14. PubMed ID: 22738999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin.
    Thorevska N; Amoateng-Adjepong Y; Sabahi R; Schiopescu I; Salloum A; Muralidharan V; Manthous CA
    Chest; 2004 Mar; 125(3):856-63. PubMed ID: 15006942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
    Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
    J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis.
    Shaieb MD; Watson BN; Atkinson RE
    J Arthroplasty; 1999 Jun; 14(4):432-8. PubMed ID: 10428223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
    Huisman MV; Quinlan DJ; Dahl OE; Schulman S
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):652-60. PubMed ID: 20923996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial.
    Fuji T; Wang CJ; Fujita S; Kawai Y; Nakamura M; Kimura T; Ibusuki K; Ushida H; Abe K; Tachibana S
    Thromb Res; 2014 Dec; 134(6):1198-204. PubMed ID: 25294589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
    Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
    Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High complication rate after total knee and hip replacement due to perioperative bridging of anticoagulant therapy based on the 2012 ACCP guideline.
    Leijtens B; Kremers van de Hei K; Jansen J; Koëter S
    Arch Orthop Trauma Surg; 2014 Sep; 134(9):1335-41. PubMed ID: 24990654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
    Turpie AG; Gallus AS; Hoek JA;
    N Engl J Med; 2001 Mar; 344(9):619-25. PubMed ID: 11228275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.